{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T02:57:19Z","timestamp":1764212239231,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study sought to explore the expression patterns of repulsive guidance molecules a (RGMa) in neuromyelitis optica spectrum disorders (NMOSD) and to explore the correlation between RGMa and the clinical features of NMOSD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 83 NMOSD patients and 22 age-matched healthy controls (HCs) were enrolled in the study from October 2017 to November 2021. Clinical parameters, including Expanded Disability Status Scale (EDSS) score, degree of MRI enhancement, and AQP4 titer were collected. The expression of serum RGMa was measured by enzyme-linked immunosorbent assay (ELISA) and compared across the four patient groups. The correlation between serum RGMa levels and different clinical parameters was also assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The average serum expression of RGMa in the NMOSD group was significantly higher than that in the HC group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Among the patient groups, the acute phase group exhibited significantly higher serum RGMa levels than did the remission group (<jats:italic>p &amp;lt; 0.001<\/jats:italic>). A multivariate analysis revealed a significant positive correlation between RGMa expression and EDSS score at admission, degree of MRI enhancement, and segmental length of spinal cord lesions. There was a significant negative correlation between the expression of RGMa in NMOSD and the time from attack to sampling or delta EDSS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The current study suggests that RGMa may be considered a potential biomarker predicting the severity, disability, and clinical features of NMOSD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.766099","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T04:27:58Z","timestamp":1643862478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Jinhua","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yetao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117225","article-title":"Neuromyelitis Optica Spectrum Disorders","volume":"420","author":"Paul","year":"2020","journal-title":"J Neurol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2020.100021","article-title":"Incidence of Neuromyelitis Optica Spectrum Disorder (NMOSD) in China: A National Population-Based Study","volume":"2","author":"Tian","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial Differences in Neuromyelitis Optica Spectrum Disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic Factors and Disease Course in Aquaporin-4 Antibody-Positive Patients With Neuromyelitis Optica Spectrum Disorder From the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11940-021-00667-3","article-title":"New Therapeutic Landscape in Neuromyelitis Optica","volume":"23","author":"Tugizova","year":"2021","journal-title":"Curr Treat Options Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12883-021-02171-2","article-title":"Correlations Among Disability, Anti-AQP4 Antibody Status and Prognosis in the Spinal Cord Involved Patients With NMOSD","volume":"21","author":"Hsu","year":"2021","journal-title":"BMC Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827666210329101335","article-title":"Recent Advances in Neuromyelitis Optica Spectrum Disorder: Pathogenesis, Mechanisms and Potential Treatments","volume":"28","author":"Du","year":"2021","journal-title":"Curr Pharm Des"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577168","article-title":"Serum AQP4-Igg Level is Associated With the Phenotype of the First Attack in Neuromyelitis Optica Spectrum Disorders","volume":"340","author":"Akaishi","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature01041","article-title":"RGM is a Repulsive Guidance Molecule for Retinal Axons","volume":"419","author":"Monnier","year":"2002","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1156","article-title":"Neogenin Mediates the Action of Repulsive Guidance Molecule","volume":"6","author":"Rajagopalan","year":"2004","journal-title":"Nat Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.771","article-title":"Plasma Proteome in Multiple Sclerosis Disease Progression","volume":"6","author":"Malekzadeh","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41598-017-18362-2","article-title":"Inhibition of Rgma Alleviates Symptoms in a Rat Model of Neuromyelitis Optica","volume":"8","author":"Harada","year":"2018","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0058-y","article-title":"Serum Levels of IL-1 Beta, IL-6, TGF- Beta, and MMP-9 in Patients Undergoing Carotid Artery Stenting and Regulation of MMP-9 in a New In Vitro Model of THP-1 Cells Activated by Stenting","volume":"25","author":"Zhang","year":"2018","journal-title":"Cell Death Differ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.brainresbull.2018.06.010","article-title":"Adenoviral Vector-Induced Silencing of Rgma Attenuates Blood-Brain Barrier Dysfunction in a Rat Model of MCAO\/Reperfusion","volume":"142","author":"Li","year":"2018","journal-title":"Brain Res Bull"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhx338","article-title":"Treatment With the Neutralizing Antibody Against Repulsive Guidance Molecule-a Promotes Recovery From Impaired Manual Dexterity in a Primate Model of Spinal Cord Injury","volume":"29","author":"Nakagawa","year":"2019","journal-title":"Cereb Cortex (New York N.Y.: 1991)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0084-17.2017","article-title":"Repulsive Guidance Molecule a (Rgma) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson\u2019s Disease","volume":"37","author":"Korecka","year":"2017","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.9951","article-title":"Repulsive Guidance Molecule a Suppresses Seizures and Mossy Fiber Sprouting via the FAK\u2212P120rasgap\u2212Ras Signaling Pathway","volume":"19","author":"Song","year":"2019","journal-title":"Mol Med Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577361","article-title":"Serum Level of IL-1\u03b2 in Patients With Inflammatory Demyelinating Disease: Marked Upregulation in the Early Acute Phase of MOG Antibody Associated Disease (MOGAD)","volume":"348","author":"Kwon","year":"2020","journal-title":"J\u00a0Neuroimmunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating Neurologic Impairment in Multiple Sclerosis: An Expanded Disability Status Scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00450","article-title":"Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders","volume":"11","author":"Kuchling","year":"2020","journal-title":"Front Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516670738","article-title":"Gadopentetate But Not Gadobutrol Accumulates in the Dentate Nucleus of Multiple Sclerosis Patients","volume":"23","author":"Schlemm","year":"2017","journal-title":"Mult Scler"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-41052\/v1","article-title":"Persistently Gadolinium-Enhancing Lesion is a Predictor of Poor Prognosis in NMOSD Attack: A Clinical Trial","volume":"18","author":"Xu","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-011-9334-z","article-title":"Repulsive Guidance Molecule-a and Demyelination: Implications for Multiple Sclerosis","volume":"7","author":"Kubo","year":"2012","journal-title":"J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","article-title":"Revisiting Remyelination: Towards a Consensus on the Regeneration of CNS Myelin","volume":"116","author":"Franklin","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.10.038","article-title":"Repulsive Guidance Molecule-a is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis","volume":"9","author":"Tanabe","year":"2014","journal-title":"Cell Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-017-0037-6","article-title":"The Roles of Rgma-Neogenin Signaling in Inflammation and Angiogenesis","volume":"37","author":"Fujita","year":"2017","journal-title":"Inflammation Regener"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.144","article-title":"T Cell Responses in the Central Nervous System,\u201d Nature Reviews","volume":"17","author":"Korn","year":"2017","journal-title":"Immunology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00333","article-title":"Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation","volume":"14","author":"Kant","year":"2020","journal-title":"Front Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1352458516639384","article-title":"Cerebrospinal Fluid Biomarkers of Inflammation and Degeneration as Measures of Fingolimod Efficacy in Multiple Sclerosis","volume":"23","author":"Novakova","year":"2017","journal-title":"Multiple Sclerosis (Houndmills Basingstoke England)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8727-1","article-title":"The Cortical Blood-Brain Barrier in Multiple Sclerosis: A Gateway to Progression","volume":"265","author":"Bell","year":"2018","journal-title":"J Neurol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1308-x","article-title":"Decreased Levels of Repulsive Guidance Molecule a in Association With Beneficial Effects of Repeated Intrathecal Triamcinolone Acetonide Application in Progressive Multiple Sclerosis Patients","volume":"122","author":"M\u00fcller","year":"2015","journal-title":"J Neural Transm (Vienna Austria: 1996)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12974-019-1445-0","article-title":"Intrathecal Triamcinolone Acetonide Exerts Anti-Inflammatory Effects on Lewis Rat Experimental Autoimmune Neuritis and Direct Anti-Oxidative Effects on Schwann Cells","volume":"16","author":"Pitarokoili","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B34","doi-asserted-by":"publisher","first-page":"105492","DOI":"10.1016\/j.nbd.2021.105492","article-title":"Elezanumab, A Clinical Stage Human Monoclonal Antibody That Selectively Targets Repulsive Guidance Molecule A to Promote Neuroregeneration and Neuroprotection in Neuronal Injury and Demyelination Models","volume":"159","author":"Huang","year":"2021","journal-title":"Neurobiol Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.10.114","article-title":"Disruption of Blood-Brain Barrier Integrity Associated With Brain Lesions in Chinese Neuromyelitis Optica Spectrum Disorder Patients","volume":"27","author":"You","year":"2019","journal-title":"Multiple Sclerosis Related Disord"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314738","article-title":"Ring-Enhancing Spinal Cord Lesions in Neuromyelitis Optica Spectrum Disorders","volume":"88","author":"Zalewski","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12883-019-1415-2","article-title":"Increased Serum IL-36\u03b2 and IL-36\u03b3 Levels in Patients With Neuromyelitis Optica Spectrum Disorders: Association With Disease Activity","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519834857","article-title":"Predictive Value of Conventional MRI Parameters in First Spinal Attacks of Neuromyelitis Optica Spectrum Disorder","volume":"26","author":"Bonnan","year":"2020","journal-title":"Mult Scler"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8050130","article-title":"Spinal Cord Involvement in MS and Other Demyelinating Diseases","volume":"8","author":"Marrodan","year":"2020","journal-title":"Biomedicines"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.766099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T04:28:01Z","timestamp":1643862481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.766099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2022.766099"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.766099","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"article-number":"766099"}}